Home
Journal Issues
Current Issue
All Issues
In Progress
Contact Us
Create Account
Login
Title
Abstract
Full Text
Keywords
Author
First Name
Last Name
Search
eISSN
:
3080-0382
Biomed adv
. 2025;2(3): 137-145. doi:
10.34172/bma.28
Original Article
Carvacrol and paclitaxel: Synergistic effect on apoptosis in breast cancer cell lines
Hassan Dariushnejad
1
, Sara Garavand
2
, Hamed Esmaeil Lashgarian
1
,
2
, Changiz Ahmadizadeh
3
, Tooba Ahmadi
2
, Ayat Moradipour
4
*
Cited by CrossRef: 0
1- Mustafa Y. Coumarins as modulators of autophagy and PI3K/mTOR signaling: implications for next-generation cancer therapies.
Biomedical Journal
. 2026;:101011
[Crossref]
2- Abuaisha A, Nekay E, Yilmaz O, Yildiz B, Mecit T, Yavas C, Papila B, Arslan H, Gumus A, Nazligul E, Akbas S, Emiroglu S. Carvacrol as a Therapeutic Candidate in Breast Cancer: Insights into Subtype-Specific Cellular Modulation.
Biology
. 2025;14(10):1443
[Crossref]
3- Ahmadi T, Ghorbanzadeh V, Hosseinnejad E, Zynivand M, Moradipour A, Dariushnejad H. Exosomal MALAT1 expression associated with the cardioprotective effects of carvacrol in acute doxorubicin-induced cardiac injury: Potential involvement of Nrf2/Keap1-related signaling.
Biomedicine & Pharmacotherapy
. 2026;200:119606
[Crossref]
Submit Your Paper
Editorial Board
Editorial Policies
Aims and Scope
For Authors
Archive
Acceptance Rate:
35%
Submission to First Decision:
20 Days
Received to Acceptance:
60 Days
Acceptance to Publication:
40 Days
*
Average article statistics from the last 12 months of data.
In
collaboration with